Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Bone Tissue × Sarcoma × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 430 Glioblastoma 156 Gliosarcoma 155 Osteosarcoma 135 Dendritic Cell Sarcoma, Interdigitating 100 Brain Neoplasms 96 Gastrointestinal Stromal Tumors 93 Central Nervous System Neoplasms 93 Glioma 73 Rhabdomyosarcoma 71 Lymphoma, Non-Hodgkin 71 Burkitt Lymphoma 70 Lymphoma 67 Recurrence 65 Precursor Cell Lymphoblastic Leukemia-Lymphoma 64 Lymphoma, Large B-Cell, Diffuse 62 Sarcoma, Ewing 59 Astrocytoma 59 Leiomyosarcoma 58 Neuroblastoma 56 Lymphoma, Follicular 56 Liposarcoma 56 Lymphoma, Mantle-Cell 51 Leukemia, Lymphocytic, Chronic, B-Cell 50 Lymphoma, B-Cell, Marginal Zone 49 Neuroectodermal Tumors, Primitive, Peripheral 47 Lymphoma, Large-Cell, Immunoblastic 47 Hodgkin Disease 47 Leukemia, Myeloid, Acute 45 Leukemia 44

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03643133 2025-12-26

SARCOME13

UNICANCER

Phase 2 Active not recruiting

Osteosarcoma, Neoplasms, Bone Tissue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡